+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Next-Generation Biomanufacturing Market by Product Type, Technology, Process Stage, End User, Operation Scale, Cell Line, Process Mode - Global Forecast to 2030- Product Image
Next-Generation Biomanufacturing Market by Product Type, Technology, Process Stage, End User, Operation Scale, Cell Line, Process Mode - Global Forecast to 2030- Product Image
Sale

Next-Generation Biomanufacturing Market by Product Type, Technology, Process Stage, End User, Operation Scale, Cell Line, Process Mode - Global Forecast to 2030

  • PDF Icon

    Report

  • 193 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5925154
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Next-generation biomanufacturing is fast becoming a strategic cornerstone for companies focused on developing, scaling, and delivering advanced biologics in a dynamic regulatory and competitive environment. Industry decision-makers are navigating innovation cycles, shifting regulatory priorities, and emerging geopolitical forces that are collectively reshaping operational strategies.

Next-Generation Biomanufacturing Market Snapshot

The Next-Generation Biomanufacturing Market grew from USD 20.69 billion in 2024 to USD 22.66 billion in 2025. It is expected to continue growing at a CAGR of 9.15%, reaching USD 35.00 billion by 2030. Demand is being driven by a combination of technological innovation, evolving biologics pipelines, regulatory shifts, and global health priorities. Senior leaders are increasingly seeking data-driven insights into how converging trends affect business resilience, manufacturing agility, and competitive positioning.

Scope & Segmentation of the Next-Generation Biomanufacturing Market

This comprehensive report delivers coverage across core segments and regional markets, drilling down to reveal growth drivers and operational nuances shaping the competitive landscape.

  • Product Type: Cell and gene therapies (including Car-T, gene editing, and other cell-based treatments), enzymes (diagnostic and industrial types), monoclonal antibodies (serving autoimmune, infectious disease, and oncology markets), recombinant proteins (cytokines, growth factors, hormones), and multiple vaccine platforms (live attenuated, mRNA, subunit, viral vector).
  • Technology: Cell-free expression systems, continuous bioprocessing platforms, modular facilities (prefabricated, skid-mounted), and single-use manufacturing solutions.
  • Process Stage: Upstream (bioreactor operation, cell culture, media preparation), downstream (chromatography, filtration, purification), and formulation/finish (fill and finish, lyophilization, specialized packaging).
  • End User: Academic and research institutions, biotech companies, contract manufacturing organizations, and commercial pharmaceutical manufacturers.
  • Operation Scale: Clinical, pilot, and commercial manufacturing environments.
  • Cell Line: CHO, E. coli, and yeast strains, each with distinct applications and operational requirements.
  • Process Mode: Batch, fed-batch, continuous, and perfusion bioprocessing methodologies.
  • Geographies: Americas (including the United States, Canada, Brazil, Mexico, Argentina), Europe, Middle East & Africa (UK, Germany, France, Russia, UAE, South Africa, and others), and Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, and additional markets).
  • Company Coverage: Detailed analysis of companies such as Novozymes A/S, Koninklijke DSM N.V., Evonik Industries AG, Ginkgo Bioworks Holdings, Amyris, Codexis, Zymergen, Genomatica, Evolva Holding, and LanzaTech.

Key Takeaways for Senior Decision-Makers

  • The landscape is shifting toward continuous processing and single-use manufacturing, enabling more agile and responsive production workflows in biomanufacturing.
  • Modular and skid-mounted facility designs empower rapid expansion and flexible reconfiguration, supporting evolving pipelines and regulatory requirements.
  • Integration of digital platforms and advanced analytics is streamlining real-time monitoring, process optimization, and quality control across the value chain.
  • Regional investment incentives and strategic partnerships are redefining global supply chains, with increased emphasis on local and cross-border collaboration.
  • Diversification of end users and operation scales creates pathways for tailored service models and technology adoption at every stage of commercialization.

Tariff Impact on Biomanufacturing Supply Chains

The introduction of new tariff measures in 2025 is prompting manufacturers to rethink sourcing and logistics for single-use consumables, critical reagents, and equipment. Strategic initiatives are focusing on building resilience through dual sourcing, exploring alternative markets, and investing in nearshoring and domestic production. These factors are also fostering new partnerships between contract manufacturers and suppliers to localize innovative capabilities and strengthen regional hubs.

Methodology & Data Sources

This report’s insights are built upon direct consultations with senior executives, in-depth interviews with subject-matter experts, and a multi-stage qualitative and quantitative data validation process. Secondary research incorporated a review of white papers, peer-reviewed journals, industry conferences, patent literature, and company disclosures.

Why This Report Matters

  • Supports strategic capital allocation and risk mitigation in a fast-evolving manufacturing landscape.
  • Provides actionable intelligence for optimizing supply chains, regulatory compliance, and cross-sector partnerships.
  • Enables senior leaders to benchmark technological readiness and identify collaborative opportunities within core and emerging markets.

Conclusion

Amid rising complexity, organizations that invest in flexible, digital, and collaborative biomanufacturing will remain best placed to capture new growth opportunities and sustain operational excellence. This report equips stakeholders with the insight and strategies needed for successful navigation of industry transformation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Next-Generation Biomanufacturing Market, by Product Type
8.1. Introduction
8.2. Cell and Gene Therapies
8.2.1. Car-T Therapies
8.2.2. Cell Therapies
8.2.3. Gene Editing Therapies
8.3. Enzymes
8.3.1. Diagnostic Enzymes
8.3.2. Industrial Enzymes
8.4. Monoclonal Antibodies
8.4.1. Autoimmune
8.4.2. Infectious Diseases
8.4.3. Oncology
8.5. Recombinant Proteins
8.5.1. Cytokines
8.5.2. Growth Factors
8.5.3. Hormones
8.6. Vaccines
8.6.1. Live Attenuated Vaccines
8.6.2. Mrna Vaccines
8.6.3. Subunit Vaccines
8.6.4. Viral Vector Vaccines
9. Next-Generation Biomanufacturing Market, by Technology
9.1. Introduction
9.2. Cell-Free Systems
9.2.1. Cell-Free Expression Kits
9.2.2. Cell-Free Synthesis Platforms
9.3. Continuous Bioprocessing
9.3.1. Continuous Chromatography
9.3.2. Inline Monitoring Systems
9.3.3. Perfusion Systems
9.4. Modular Facilities
9.4.1. Prefabricated Modules
9.4.2. Skid-Mounted Systems
9.5. Single-Use Systems
9.5.1. Single-Use Bags
9.5.2. Single-Use Bioreactors
9.5.3. Single-Use Tubing and Connectors
10. Next-Generation Biomanufacturing Market, by Process Stage
10.1. Introduction
10.2. Downstream Processing
10.2.1. Chromatography
10.2.2. Filtration
10.2.3. Purification
10.3. Formulation
10.3.1. Fill and Finish
10.3.2. Lyophilization
10.3.3. Packaging
10.4. Upstream Processing
10.4.1. Bioreactor Operation
10.4.2. Cell Culture
10.4.3. Media Preparation
11. Next-Generation Biomanufacturing Market, by End User
11.1. Introduction
11.2. Academic and Research Institutions
11.3. Biotech Companies
11.4. Contract Manufacturing Organizations
11.5. Pharmaceutical Companies
12. Next-Generation Biomanufacturing Market, by Operation Scale
12.1. Introduction
12.2. Clinical Scale
12.3. Commercial Scale
12.4. Pilot Scale
13. Next-Generation Biomanufacturing Market, by Cell Line
13.1. Introduction
13.2. Cho Cell
13.2.1. Cho-DG44
13.2.2. Cho-K1
13.3. E. Coli
13.3.1. Bl21
13.3.2. K12
13.4. Yeast
13.4.1. Pichia Pastoris
13.4.2. Saccharomyces Cerevisiae
14. Next-Generation Biomanufacturing Market, by Process Mode
14.1. Introduction
14.2. Batch
14.3. Continuous
14.4. Fed Batch
14.5. Perfusion
15. Americas Next-Generation Biomanufacturing Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Next-Generation Biomanufacturing Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Next-Generation Biomanufacturing Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Novozymes a/S
18.3.2. Koninklijke DSM N.V.
18.3.3. Evonik Industries AG
18.3.4. Ginkgo Bioworks Holdings, Inc.
18.3.5. Amyris, Inc.
18.3.6. Codexis, Inc.
18.3.7. Zymergen Inc.
18.3.8. Genomatica, Inc.
18.3.9. Evolva Holding SA
18.3.10. LanzaTech, Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. NEXT-GENERATION BIOMANUFACTURING MARKET MULTI-CURRENCY
FIGURE 2. NEXT-GENERATION BIOMANUFACTURING MARKET MULTI-LANGUAGE
FIGURE 3. NEXT-GENERATION BIOMANUFACTURING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. NEXT-GENERATION BIOMANUFACTURING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. NEXT-GENERATION BIOMANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NEXT-GENERATION BIOMANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CAR-T THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY GENE EDITING THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTIC ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY INDUSTRIAL ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY HORMONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MRNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VIRAL VECTOR VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE EXPRESSION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYNTHESIS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY INLINE MONITORING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PERFUSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PREFABRICATED MODULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SKID-MOUNTED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE BAGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE TUBING AND CONNECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FILTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FILL AND FINISH, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY LYOPHILIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BIOREACTOR OPERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MEDIA PREPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CLINICAL SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COMMERCIAL SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PILOT SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO-DG44, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO-K1, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BL21, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY K12, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PICHIA PASTORIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SACCHAROMYCES CEREVISIAE, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FED BATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PERFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, 2018-2030 (USD MILLION)
TABLE 137. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 140. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 142. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 143. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 144. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 145. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 146. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 148. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 149. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, 2018-2030 (USD MILLION)
TABLE 150. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 151. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 152. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 153. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 154. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 155. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2018-2030 (USD MILLION)
TABLE 157. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
TABLE 158. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, 2018-2030 (USD MILLION)
TABLE 159. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, 2018-2030 (USD MILLION)
TABLE 160. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, 2018-2030 (USD MILLION)
TABLE 161. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2018-2030 (USD MILLION)
TABLE 162. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 164. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 165. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 166. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 167. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 168. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 170. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 171. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, 2018-2030 (USD MILLION)
TABLE 172. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 173. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 174. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 175. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 176. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 177. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2018-2030 (USD MILLION)
TABLE 179. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
TABLE 180. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, 2018-2030 (USD MILLION)
TABLE 181. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, 2018-2030 (USD MILLION)
TABLE 182. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, 2018-2030 (USD MILLION)
TABLE 183. MEXICO NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2018-2030 (USD MILLION)
TABLE 184. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 186. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 187. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 188. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 189. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 190. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 192. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 193. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, 2018-2030 (USD MILLION)
TABLE 194. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 195. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 196. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 197. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 198. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 199. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2018-2030 (USD MILLION)
TABLE 201. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
TABLE 202. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, 2018-2030 (USD MILLION)
TABLE 203. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, 2018-2030 (USD MILLION)
TABLE 204. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, 2018-2030 (USD MILLION)
TABLE 205. BRAZIL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2018-2030 (USD MILLION)
TABLE 206. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 208. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 209. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 210. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 211. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 212. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 214. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 215. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, 2018-2030 (USD MILLION)
TABLE 216. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 217. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 218. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 219. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 220. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 221. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2018-2030 (USD MILLION)
TABLE 223. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
TABLE 224. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, 2018-2030 (USD MILLION)
TABLE 225. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, 2018-2030 (USD MILLION)
TABLE 226. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, 2018-2030 (USD MILLION)
TABLE 227. ARGENTINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2018-2030 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2018-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, 2018-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, 2018-2030 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, 2018-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2018-2030 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 252. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 254. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 256. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 260. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, 2018-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 262. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 264. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 266. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2018-2030 (USD MILLION)
TABLE 268. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, 2018-2030 (USD MILLION)
TABLE 270. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, 2018-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, 2018-2030 (USD MILLION)
TABLE 272. UNITED KINGDOM NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2018-2030 (USD MILLION)
TABLE 273. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 275. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 276. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 277. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 278. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 279. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 281. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 282. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, 2018-2030 (USD MILLION)
TABLE 283. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 284. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 285. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 286. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 287. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 288. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2018-2030 (USD MILLION)
TABLE 290. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
TABLE 291. GERMANY NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, 2018-2030 (USD MILLION)
TABLE 292. GERMANY NEXT-GENERATION BIOMANUFACT

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Next-Generation Biomanufacturing market report include:
  • Novozymes A/S
  • Koninklijke DSM N.V.
  • Evonik Industries AG
  • Ginkgo Bioworks Holdings, Inc.
  • Amyris, Inc.
  • Codexis, Inc.
  • Zymergen Inc.
  • Genomatica, Inc.
  • Evolva Holding SA
  • LanzaTech, Inc.

Table Information

Report AttributeDetails
No. of Pages193
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 22.66 Billion
Forecasted Market Value ( USD ) by 2030 $ 35 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Biomanufacturing Viral Detection & Quantification Market by Product, Technology, Application, End User, Sample Type - Global Forecast to 2030 - Product Image

Biomanufacturing Viral Detection & Quantification Market by Product, Technology, Application, End User, Sample Type - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Digital Biomanufacturing Market by Product Type, Process Stage, Technology, End User, Application - Global Forecast to 2030 - Product Image

Digital Biomanufacturing Market by Product Type, Process Stage, Technology, End User, Application - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Biomanufacturing - Global Strategic Business Report - Product Image

Biomanufacturing - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
Digital Biomanufacturing - Global Strategic Business Report - Product Image

Digital Biomanufacturing - Global Strategic Business Report

  • Report
  • 341 Pages
  • Global
From
The Global Market for Industrial Biomanufacturing 2025-2035 - Product Image

The Global Market for Industrial Biomanufacturing 2025-2035

  • Report
  • 1159 Pages
  • Global

About the Next Generation Biomanufacturing Market

The Next Generation Biomanufacturing market is a subset of the biotechnology industry that focuses on the development of advanced manufacturing technologies for the production of biopharmaceuticals. This includes the use of cell and gene therapies, as well as the development of novel bioprocessing techniques. These technologies are used to improve the efficiency and cost-effectiveness of biopharmaceutical production, while also reducing the environmental impact of the process. The Next Generation Biomanufacturing market is driven by the increasing demand for biopharmaceuticals, as well as the need to reduce the cost of production. This has led to the development of new technologies such as single-use bioreactors, automated bioprocessing systems, and advanced analytics. These technologies are being used to improve the efficiency and cost-effectiveness of biopharmaceutical production, while also reducing the environmental impact of the process. Some of the companies in the Next Generation Biomanufacturing market include Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Lonza, and Sartorius AG. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.